2014 NHMRC grant results

CTC successful NHMRC grant funding

Congratulations to CTC researchers and collaborators who have been successfully awarded over $8 million in National Health and Medical Research Council (NHMRC) grants. Research projects in diabetes, neonatal disorders, health economics and cancer were funded. Results of grant applications to Cancer Australia and Cancer Council will be released later this year.

Read more about the grants awarded here:


Prof Tony Keech and his team were awarded a 5-year Centres of Research Excellence grant for Diabetic Retinopathy: Closing the Loop for Diabetic Eye Care and Complication Risk Mitigation' which will aim to deliver preservation of vision and quality of life for many people with diabetes globally.


Professor Deborah Schofield as a co-chief investigator on the Critical Illness in Children Study collaborating with Nadine Kasparian from the Unviersity of New South Wales.


Associate Professor Ju Lee Oei and Professor Tarnow-Mordi and their team who were awarded $2 198 371 for the very important TORPIDO-2 trial (Targeted Oxygen for Resuscitation of Preterm Infants Effects on Developmental Outcomes 2') which aims to provide the necessary evidence to guide clinicians worldwide about resuscitation of preterm infants.

Professor Tarnow-Mordi and his team was also awarded $854 490 for continuing follow-up for the Australlan Placental Transfusion Study which aims to answer the question: Does placental transfusion prevent death and disability in very preterm infants? 


Dr Alison Brand, Dr Julie Martyn and others were awarded $1 271 184 for the STATEC trial (Selective Targeting of Adjuvant Therapy for Endometrial Cancer). The results of this trial will change practice as it will provide the necessary evidence for treatment of women with high risk endometrial cancer. 

CIA A/Prof Andrew Stevenson with his team including CTC's Dr Wendy Hague were successful in receiving $573 259 for the extension of the A La CaRT trial: Australasian Laparoscopic Cancer of the Rectum Trial, a phase III prospective randomised trial comparing laparoscopic-assisted resection versus open resection for rectal cancer. 

These projects represent research which aim to improve health outcomes in Australia and around the world.

22 October 2014